What happened in optometry this week: January 13 - January 17

Blog
Article

Catch up on what happened in optometry during the week of January 13-January 17.

Catch up with what Optometry Times shared this week:

FDA approves Zeiss MEL 90 excimer laser

By Emily Kaiser Maharjan, Assistant Managing Editor

The FDA has granted its approval to the excimer laser MEL 90 from Zeiss Meditech for all 3 major indications: myopia, hyperopia, and mixed astigmatism. The laser fully integrates into the Corneal Refractive Workflow from Zeiss as a complement to Visumax 800 and SMILE pro software to streamline surgical correction with positive outcomes. The MEL 90 is currently available in the US.

Read here...

New The Vision Council report assesses eye care providers' frame buying habits

By Jordana Joy, Associate Editor

A new research report from The Vision Council took a deep dive into how eye care providers source and select eyeglasses frames for their practices.1 Focused inSights 2024: Frame Buyers assessed who makes frame purchases at practices, how often purchases are made, and where products are sourced, in addition to the choices that eye care providers make about styles and the materials of frames that they purchase most often, according to a news release.

Read here...

FDA accepts revised supplemental New Drug Application for Izervay

By Sydney M Crago, Editor, Modern Retina

The US Food and Drug Administration (FDA) has accepted the revised supplemental New Drug Application (sNDA) for Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) on January 6, 2025. This revision was in response to the Agency's November 2024 Complete Response Letter.1

According to the company’s press release1, the application was refiled following a December 20, 2024, meeting between the FDA and Astellas and has been designated as a Class 1 resubmission, with a 60-day review period. This sets the target action date for February 26, 2025.

Read here...

Positive association found between the Dietary Inflammatory Index and non-refractive visual impairment in US patients

By Lynda Charters

A Chinese study1 identified a positive association between the dietary inflammatory index (DII) and non-refractive visual impairment among US populations, that is, the loss of vision resulting from ocular diseases and not the shape of the eye, according to the coauthors.

Yudie Hu, MD, is from the Department of Breast, The First Hospital of Hunan University of Chinese Medicine, Changsha, China; Jiang Zheng, MD, is from the Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China; and Lun He, MD, is from the Department of Ophthalmology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou.

Read here...

AOA evidence-based clinical practice guideline aims to improve treatment for patients with POAG

By Jordana Joy, Associate Editor

At the tail end of 2024, the American Optometric Association (AOA) published Care of the Patient with Primary Open-Angle Glaucoma, an evidence based clinical practice guideline.1 The guideline’s first edition is “designed to elevate health care quality by providing doctor of optometry a platform to build quality clinical care to ensure patients are diagnosed and treated based on scientific research,” according to a news release.

Read here...

Recent Videos
Jeffrey Walline, OD, PhD, FAAO, gives an overview of the AAO's 2024 and what to expect in 2025 and beyond.
Dr Jamie Kuzniar discusses higher order aberrations and premium scleral lenses
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
© 2025 MJH Life Sciences

All rights reserved.